After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
The company is listed on the NASDAQ and operates within the Biotechnology industry segment. The current market capitalization of MoonLake Immunotherapeutics is $3.82B. A total of 1.03 million shares were traded on the day, compared to an average of 565.56K shares.
In the most recent transaction, Moukheibir Catherine sold 23,500 shares of MLTX for 48.79 per share on Jul 03 ’25. After the transaction, the Director now owns 0 company shares. In a previous transaction on Jul 03 ’25, Moukheibir Catherine bought 23,500 shares at 48.79 per share.
Among the insiders who sold shares, BVF PARTNERS L P/IL disposed of 2,000,000 shares on Oct 04 ’24 at a per-share price of $50.00. This resulted in the Director holding 1,287,768 shares of MLTX after the transaction. In another insider transaction, Sturge Simon sold 171,000 shares at $53.72 per share on Oct 04 ’24. Company shares held by the Director now total 171,980.
It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. In terms of 52-week highs and lows, MLTX has a high of $58.99 and a low of $31.42.
As of this writing, MLTX has an earnings estimate of -$0.9 per share for the current quarter. EPS was calculated based on a consensus of 7.0 estimates, with a high estimate of -$0.84 per share and a lower estimate of -$0.96. The company reported an EPS of -$0.56 in the last quarter
Balance Sheet Annually/Quarterly
An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. MLTX’s latest balance sheet shows that the firm has $8.04M in Cash & Short Term Investments as of fiscal 2021. There were $15.00M in debt and $21.09M in liabilities at the time. Its Book Value Per Share was $5.57, while its Total Shareholder’s Equity was -$11.65M.
Analysts Opinion
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for MLTX is Buy with a score of 4.67.
